The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer's and Parkinson's Diseases
- PMID: 38461204
- PMCID: PMC10924707
- DOI: 10.1007/s10571-024-01461-w
The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer's and Parkinson's Diseases
Abstract
Clearance of accumulated protein aggregates is one of the functions of autophagy. Recently, a clearer understanding of non-coding RNAs (ncRNAs) functions documented that ncRNAs have important roles in several biological processes associated with the development and progression of neurodegenerative disorders. Subtypes of ncRNA, including microRNA (miRNA), long noncoding RNA (lncRNA), and circular RNA (circRNA), are commonly dysregulated in neurodegenerative disorders such as Alzheimer and Parkinson diseases. Dysregulation of these non-coding RNAs has been associated with inhibition or stimulation of autophagy. Decreased miR-124 led to decreased/increased autophagy in experimental model of Alzheimer and Parkinson diseases. Increased BACE1-AS showed enhanced autophagy in Alzheimer disease by targeting miR-214-3p, Beclin-1, LC3-I/LC3-II, p62, and ATG5. A significant increase in NEAT1led to stimulated autophagy in experimental model of PD by targeting PINK1, LC3-I, LC3-II, p62 and miR-374c-5p. In addition, increased BDNF-AS and SNHG1 decreased autophagy in MPTP-induced PD by targeting miR-125b-5p and miR-221/222, respectively. The upregulation of circNF1-419 and circSAMD4A resulted in an increased autophagy by regulating Dynamin-1 and miR-29c 3p, respectively. A detailed discussion of miRNAs, circRNAs, and lncRNAs in relation to their autophagy-related signaling pathways is presented in this study.
Keywords: Autophagy; Long non-coding (lnc) RNA; Neurodegenerative disorders; Non-coding RNAs; microRNA.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.Neuroscience. 2021 Feb 10;455:52-64. doi: 10.1016/j.neuroscience.2020.10.028. Epub 2020 Nov 13. Neuroscience. 2021. PMID: 33197504
-
LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p.Brain Res Bull. 2020 Apr;157:119-127. doi: 10.1016/j.brainresbull.2020.02.003. Epub 2020 Feb 10. Brain Res Bull. 2020. PMID: 32057951
-
lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's disease by impairing miR-374c-5p.Acta Biochim Biophys Sin (Shanghai). 2021 Jul 5;53(7):870-882. doi: 10.1093/abbs/gmab055. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33984130
-
Expression of Linear and Circular lncRNAs in Alzheimer's Disease.J Mol Neurosci. 2022 Feb;72(2):187-200. doi: 10.1007/s12031-021-01900-z. Epub 2021 Aug 20. J Mol Neurosci. 2022. PMID: 34415549 Review.
-
The Emerging Role of Autophagy-Associated lncRNAs in the Pathogenesis of Neurodegenerative Diseases.Int J Mol Sci. 2023 Jun 2;24(11):9686. doi: 10.3390/ijms24119686. Int J Mol Sci. 2023. PMID: 37298636 Free PMC article. Review.
Cited by
-
Overexpression of LINC00672 promotes autophagy in Alzheimer's disease by upregulating GPNMB.PLoS One. 2025 May 14;20(5):e0322708. doi: 10.1371/journal.pone.0322708. eCollection 2025. PLoS One. 2025. PMID: 40367036 Free PMC article.
-
Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia.Front Cell Neurosci. 2024 Jul 26;18:1429977. doi: 10.3389/fncel.2024.1429977. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39131043 Free PMC article. Review.
-
Apelin-13-Mediated Upregulation of METTL3 Ameliorates Alzheimer's Disease via Inhibiting Neuroinflammation Through m6A-Dependent Regulation of lncRNA BDNF-AS.Biomolecules. 2025 Aug 18;15(8):1188. doi: 10.3390/biom15081188. Biomolecules. 2025. PMID: 40867632 Free PMC article.
-
Shisandra Decoction Alleviates Parkinson's Disease Symptoms in a Mouse Model Through PI3K/AKT/mTOR Signalling Pathway.Neuropsychiatr Dis Treat. 2024 Oct 23;20:2011-2027. doi: 10.2147/NDT.S476969. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 39464379 Free PMC article.
References
-
- Agarwal S, Tiwari SK, Seth B, Yadav A, Singh A, Mudawal A, Chauhan LKS, Gupta SK, Choubey V, Tripathi A (2015) Activation of autophagic flux against xenoestrogen bisphenol-A-induced hippocampal neurodegeneration via AMP kinase (AMPK)/mammalian target of rapamycin (mTOR) pathways. J Biol Chem 290:21163–21184 - PMC - PubMed
-
- Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C (2010) Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol 67:1116–1122 - PMC - PubMed
-
- Ansari A, Maffioletti E, Milanesi E, Marizzoni M, Frisoni GB, Blin O, Richardson JC, Bordet R, Forloni G, Gennarelli M (2019) miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer’s disease. Neurobiol Aging 82:102–109 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials